Although little is known about the mechanism by which nesfatin-1 affects MI and CAD progression, a couple of studies carried out in rats have proposed that nesfatin-1 could act as an anti-inflammatory mediator with cardioprotective effects in these pathologies. Here, NUCB2 is linked to myocardial infarction.